Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.
暂无分享,去创建一个
D. Danley | R. McPherson | J. Treadway | E. Barrett | Sandra J Armento | W. H. Martin | R. W. Stevenson | D. Hoover | I. Stock | S. J. Armento | William Martin
[1] S. Turner,et al. Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. , 1997, The Journal of clinical investigation.
[2] F. Nuttall,et al. The effect of caffeine and caffeine analogs on rat liver phosphorylase a activity. , 1997, The Journal of pharmacology and experimental therapeutics.
[3] J. Wahren,et al. Contributions of gluconeogenesis to glucose production in the fasted state. , 1996, The Journal of clinical investigation.
[4] K. Petersen,et al. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. , 1996, The Journal of clinical investigation.
[5] L. Johnson,et al. Specific inhibition of glycogen phosphorylase by a spirodiketopiperazine at the anomeric position of glucopyranose , 1995 .
[6] L. Johnson,et al. Effects of C-1-substituted glucose analogue on the activation states of glycogen synthase and glycogen phosphorylase in rat hepatocytes. , 1995, The Biochemical journal.
[7] L. Johnson,et al. POTENT INHIBITION OF GLYCOGEN PHOSPHORYLASE BY A SPIROHYDANTOIN OF GLUCOPYRANOSE : FIRST PYRANOSE ANALOGUES OF HYDANTOCIDIN , 1995 .
[8] L. Johnson,et al. Effects of novel analogues of D-glucose on glycogen phosphorylase activities in crude extracts of liver and skeletal muscle. , 1995, European journal of biochemistry.
[9] R. McPherson,et al. Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene. , 1994, The Journal of biological chemistry.
[10] A. Nussler,et al. A New Technique for Isolating and Culturing Human Hepatocytes from Whole or Split Livers not Used for Transplantation , 1994, Cell transplantation.
[11] L. Johnson,et al. Design of inhibitors of glycogen phosphorylase: a study of alpha- and beta-C-glucosides and 1-thio-beta-D-glucose compounds. , 1994, Biochemistry.
[12] E. Barrett,et al. Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms. , 1993, Metabolism: clinical and experimental.
[13] R. McPherson,et al. Actions of the novel antidiabetic agent englitazone in rat hepatocytes. , 1993, Metabolism: clinical and experimental.
[14] E. Barrett,et al. Hepatic glucose metabolism and insulin resistance in NIDDM and obesity. , 1993, Bailliere's clinical endocrinology and metabolism.
[15] R. Fletterick,et al. Purification of glycogen phosphorylase isozymes by metal-affinity chromatography. , 1992, Journal of chromatography.
[16] R. Shulman,et al. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.
[17] D. Davies,et al. Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes. , 1992, Biochemistry.
[18] R. Bressler,et al. New Pharmacological Approaches to Therapy of NIDDM , 1992, Diabetes Care.
[19] E. Pekel,et al. The nucleotide sequence of rat liver glycogen phosphorylase cDNA. , 1992, Biochimica et biophysica acta.
[20] A. Consoli. Role of Liver in Pathophysiology of NIDDM , 1992, Diabetes Care.
[21] R. DeFronzo,et al. Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.
[22] R G Shulman,et al. Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. , 1991, Science.
[23] L. Johnson,et al. Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes. , 1991, Biochemistry.
[24] R. Fletterick,et al. An engineered liver glycogen phosphorylase with AMP allosteric activation. , 1991, The Journal of biological chemistry.
[25] R. Shulman,et al. Simultaneous synthesis and degradation of rat liver glycogen. An in vivo nuclear magnetic resonance spectroscopic study. , 1990, The Journal of clinical investigation.
[26] S. Sprang,et al. Analysis of an allosteric binding site: the nucleoside inhibitor site of phosphorylase alpha. , 1982, Biochemistry.
[27] R. Fletterick,et al. Regulation of the dephosphorylation of glycogen phosphorylase a and synthase b by glucose and caffeine in isolated hepatocytes. , 1981, Canadian journal of biochemistry.
[28] P. A. Lanzetta,et al. An improved assay for nanomole amounts of inorganic phosphate. , 1979, Analytical biochemistry.
[29] R. Fletterick,et al. Synergistic regulation of phosphorylase a by glucose and caffeine. , 1978, The Journal of biological chemistry.
[30] R. Fletterick,et al. The regulation of glycogen phosphorylase alpha by nucleotide derivatives. Kinetic and x-ray crystallographic studies. , 1978, The Journal of biological chemistry.
[31] N. Madsen,et al. Kinetic mechanism of phosphorylase a. I. Initial velocity studies. , 1970, Canadian journal of biochemistry.
[32] D. Maclean,et al. Mass spectra of labelled methylquinolines , 1970 .
[33] H. Yki-Järvinen. The liver as a target for therapy in non-insuling dependent diabetes mellitus , 1994 .
[34] R. Fletterick,et al. The family of glycogen phosphorylases: structure and function. , 1989, Critical reviews in biochemistry and molecular biology.
[35] D. Coleman,et al. Laboratory animals exhibiting obesity and diabetes syndromes. , 1977, Metabolism: clinical and experimental.